Free Trial

Innate Pharma (IPHA) SEC Filings & 10K Form

Innate Pharma logo
$1.69 +0.20 (+13.46%)
(As of 11/20/2024 ET)

Recent Innate Pharma SEC Filings

DateFilerForm TypeView
11/20/2024
5:02 AM
Innate Pharma SA (Filer)
Innate Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/19/2024
5:01 AM
Innate Pharma SA (Filer)
Innate Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/13/2024
5:00 AM
Innate Pharma SA (Filer)
Innate Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/08/2024
5:00 AM
Innate Pharma SA (Filer)
Innate Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/07/2024
5:00 AM
Innate Pharma SA (Filer)
Innate Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/29/2024
6:03 AM
Innate Pharma SA (Filer)
Innate Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/15/2024
5:11 AM
Innate Pharma SA (Filer)
Innate Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/30/2024
5:15 AM
Innate Pharma SA (Filer)
Innate Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/23/2024
5:03 AM
Innate Pharma SA (Filer)
Innate Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/12/2024
5:15 AM
Innate Pharma SA (Filer)
Innate Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/12/2024
5:07 AM
Innate Pharma SA (Filer)
Innate Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/11/2024
3:00 PM
Innate Pharma SA (Filer)
Innate Pharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
09/09/2024
5:13 AM
Innate Pharma SA (Filer)
Innate Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/05/2024
5:10 AM
Innate Pharma SA (Filer)
Innate Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/04/2024
5:11 AM
Innate Pharma SA (Filer)
Innate Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/25/2024
5:06 AM
Innate Pharma SA (Filer)
Innate Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/18/2024
6:43 AM
Innate Pharma SA (Filer)
Innate Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/17/2024
5:02 AM
Innate Pharma SA (Filer)
Innate Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/04/2024
5:03 AM
Innate Pharma SA (Filer)
Innate Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/28/2024
5:03 AM
Innate Pharma SA (Filer)
Innate Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/24/2024
5:35 AM
Innate Pharma SA (Filer)
Innate Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/15/2024
5:01 AM
Innate Pharma SA (Filer)
Innate Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/14/2024
5:07 AM
Innate Pharma SA (Filer)
Innate Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/07/2024
5:03 AM
Innate Pharma SA (Filer)
Innate Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/15/2024
5:02 AM
Innate Pharma SA (Filer)
Innate Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/15/2024
5:00 AM
Innate Pharma SA (Filer)
Innate Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/10/2024
5:51 AM
Innate Pharma SA (Filer)
Innate Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/04/2024
7:03 AM
Innate Pharma SA (Filer)
Innate Pharma (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
03/21/2024
8:20 AM
Innate Pharma SA (Filer)
Innate Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/21/2024
5:01 AM
Innate Pharma SA (Filer)
Innate Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/19/2024
5:33 AM
Innate Pharma SA (Filer)
Innate Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/14/2024
6:00 AM
Innate Pharma SA (Filer)
Innate Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/06/2024
5:00 AM
Innate Pharma SA (Filer)
Innate Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/06/2024
5:00 AM
Innate Pharma SA (Filer)
Innate Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/21/2024
5:00 AM
Innate Pharma SA (Filer)
Innate Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/06/2024
4:00 PM
Innate Pharma SA (Filer)
Innate Pharma (Filer)
Form 424B5
02/06/2024
4:05 PM
Innate Pharma SA (Filer)
Innate Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/16/2024
11:15 PM
Innate Pharma SA (Filer)
Innate Pharma (Filer)
Form EFFECT
01/12/2024
5:00 AM
Innate Pharma SA (Filer)
Innate Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/05/2024
5:09 AM
Innate Pharma SA (Filer)
Innate Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/04/2024
5:00 AM
Innate Pharma SA (Filer)
Innate Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
Trump won. Buy this coin now. (Ad)

Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.

01/04/2024
5:01 AM
Innate Pharma SA (Filer)
Innate Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/20/2023
3:45 PM
Innate Pharma SA (Filer)
Innate Pharma (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
12/20/2023
3:30 PM
Innate Pharma SA (Filer)
Innate Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/19/2023
5:00 AM
Innate Pharma SA (Filer)
Innate Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/18/2023
10:40 AM
Innate Pharma SA (Filer)
Innate Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/11/2023
5:00 AM
Innate Pharma SA (Filer)
Innate Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/11/2023
5:01 AM
Innate Pharma SA (Filer)
Innate Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/27/2023
5:00 AM
Innate Pharma SA (Filer)
Innate Pharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:IPHA) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners